Futures in Life Sciences Program - Finance, Legal, and Operations

Tuesday, November 20 2012
5:30 pm – 8:00 pm

Location: MassBio, 300 Tech Square, 8th Floor, Cambridge

Propel Careers, MassBio, and the MassBioEd have joined together to organize a series of networking and panel events focused on raising awareness of career paths that exist in life sciences for individuals with advanced degrees. This Futures in Life Science program will bring together experts across a wide range of disciplines and functional areas within the life science industry, who will detail their roles and will provide a rich context for the audience to gain a clear understanding of the skills, aptitudes, competencies, and personalities that thrive in their particular functions. 

Attendance for this program is open to current graduate students, post doctoral fellows, and medical residents who are interested in careers in the life sciences industry.  Space is limited to 100 individuals.

The event will focus on the various career options within the Finance, Legal, and Operations area of the life sciences sector. 

Click here to register

 

Meeting Agenda:

5:30pm-6:00pm– Registration and Open Networking 

6:00pm-6:10pm – Introductions, Overview, and Recognition of Sponsors

6:10pm-7:30pm – Panel Discussio

Moderator:  John Hession, J.D., Partner, Cooley LLP

Panelists:

  • Tony Martignetti, Corporate Controller at Sarepta Therapeutics
  • Drew Lowery, Biotechnology Group Leader, Global Prior Art
  • Joanne Kamens, Executive Director, Addgene
  • Stephen Garbacz, Sr. Director of Finance, Epizyme

7:30pm-8:00pm – Open Networking

 

To register: http://fils82012.eventbrite.com/

 

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

MassBio is moving! As of April 2nd our offices will be located at 300 Technology Square, 8th Floor, just a few blocks across Kendall Square. Find directions online. Parking is available in the Technology Square Garage, off of Portland Street or Tech Square Drive.

 

Share MassBio

 

BioProcess

EvaluatePharma 

MassBio